Liu QY - Search Results

1

CASC2 inhibits the growth, migration, and invasion of thyroid cancer cells through sponging miR-18a-5p/FIH1 axis.

Liu QY, Gao LY, Xu L, Zhang XL, Zhang LJ, Gong XL, Luo SB, Zhao R, Cheng RC. Liu QY, et al. Kaohsiung J Med Sci. 2021 Apr;37(4):268-275. doi: 10.1002/kjm2.12331. Epub 2020 Dec 17. Kaohsiung J Med Sci. 2021. PMID: 33336500 Free article.

2

[Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].

Diao C, Cheng RC, Zhang JM, Wei XP, Su YJ, Liu QY, Xu JB. Diao C, et al. Among authors: liu qy. Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):147-50. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18646702 Clinical Trial. Chinese.

3

Comparison of left- and right-sided colorectal cancer to explore prognostic signatures related to pyroptosis.

Luo S, Cai S, Zhao R, Xu L, Zhang X, Gong X, Zhang Z, Liu Q. Luo S, et al. Heliyon. 2024 Mar 14;10(7):e28091. doi: 10.1016/j.heliyon.2024.e28091. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38571659 Free PMC article.

4

Investigation of the role of cullin 4A overexpression in human liver cancer.

Chen G, Zhao X, Tan Z, Wang D, Luo D, Zhang P, Cao J, Wang F, Liu Q, Li L. Chen G, et al. Mol Med Rep. 2018 Sep;18(3):2531-2540. doi: 10.3892/mmr.2018.9233. Epub 2018 Jun 29. Mol Med Rep. 2018. PMID: 30015884 Free PMC article.

5

Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model.

Yu L, Liu Q, Huo J, Wei F, Guo W. Yu L, et al. Cell Mol Biol (Noisy-le-grand). 2020 May 15;66(2):36-40. Cell Mol Biol (Noisy-le-grand). 2020. PMID: 32415924

6

[Effect of different approaches of lentiviral vector transfection on target gene expression in rat liver].

Zhao Y, Li L, Ma J, Bai J, Liu Q. Zhao Y, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan;34(1):96-9. Nan Fang Yi Ke Da Xue Xue Bao. 2014. PMID: 24463126 Chinese.

7

Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.

Li Z, Gao H, Zhang X, Liu Q, Chen G. Li Z, et al. BMC Gastroenterol. 2022 Sep 24;22(1):427. doi: 10.1186/s12876-022-02496-3. BMC Gastroenterol. 2022. PMID: 36153509 Free PMC article.

8

Protective role of naringin loaded solid nanoparticles against aflatoxin B1 induced hepatocellular carcinoma.

Wang W, Liu Q, Liang X, Kang Q, Wang Z. Wang W, et al. Chem Biol Interact. 2022 Jan 5;351:109711. doi: 10.1016/j.cbi.2021.109711. Epub 2021 Oct 27. Chem Biol Interact. 2022. PMID: 34717916

9

A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.

Chen G, Liu H, Hu ZQ, Bai JH, Liu QY, Zhao YP, Gan XM, Wang F, Wang DD, Ma LJ, Li L. Chen G, et al. Among authors: liu h, liu qy. Eur J Gastroenterol Hepatol. 2015 Aug;27(8):901-6. doi: 10.1097/MEG.0000000000000388. Eur J Gastroenterol Hepatol. 2015. PMID: 26011237

10

Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy.

Liu QY, Zhang WZ, Xia HT, Leng JJ, Wan T, Liang B, Yang T, Dong JH. Liu QY, et al. World J Gastroenterol. 2014 Dec 14;20(46):17491-7. doi: 10.3748/wjg.v20.i46.17491. World J Gastroenterol. 2014. PMID: 25516663 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

898 results

Search Page

Filters